INS and obesity due to melanocortin 4 receptor deficiency: Together, the obesity-associated impairment of insulin and anabolic sensitivity contribute to pathophysiological consequences with ageing, including the decline of skeletal muscle mass and function, termed sarcopenia [3, 4].